As DSCSA enforcement expectations continue to evolve, pharmaceutical supply chains are shifting from theoretical readiness to operational execution. Serialization is only part of the equation. The real complexity lies in interoperable data exchange across manufacturers, CMOs, wholesalers, and distributors. This is where GS1 standards certification becomes meaningful.
GS1 aligned vs. GS1 standards certified
Many traceability platforms describe themselves as “GS1 aligned”. That typically means the solution is designed to support GS1 standards such as EPCIS, GTINs, and aggregation concepts. However, alignment is often self-attested. GS1 standards certification is different.
Independent certification through a GS1-recognized certification authority such as Gateway Checker validates that EPCIS outputs:
- Conform to GS1 event structure requirements
- Properly support aggregation and shipment scenarios
- Can be reliably exchanged across trading partner systems
That independent validation helps reduce downstream exceptions, remediation efforts, and integration risk.
Why interoperability is the real DSCSA challenge
Most DSCSA-related failures do not occur inside a single system. They occur when data is exchanged between partners.
If EPCIS data cannot be consumed reliably by a trading partner or repository, the impact can include:
- Shipment delays
- Data corrections and rework
- Increased audit scrutiny
- Strained partner relationships
Independent certification validates a critical foundation: standards-based EPCIS data exchange. It does not guarantee DSCSA compliance on its own but it significantly reduces one of the most common points of failure.
The role of Gateway Checker
Gateway Checker serves as an independent certification authority for GS1 EPCIS conformance. Through structured testing scenarios, it validates interoperability readiness and confirms that EPCIS data meets defined GS1 requirements.
Certification through Gateway Checker provides objective, third-party validation which strengthens trust across regulated supply chains.
STEPLogic Trace 9.1 and standards-based traceability
With the release of STEPLogic Trace 9.1, the platform achieved GS1 standards certification through Gateway Checker, validating EPCIS outputs used in regulated pharmaceutical workflows.
STEPLogic is also an Executive-level Solution Partner in the GS1 US Solution Partner Program, reflecting ongoing alignment with GS1 standards evolution and industry collaboration.
Together, these elements reinforce a standards-first approach to traceability that is designed to scale as regulatory expectations continue to mature.
What this means for pharma teams
For pharmaceutical manufacturers, CMOs, wholesalers, and distributors, independent certification provides:
- Greater confidence in partner data exchange
- Reduced interoperability risk
- Fewer EPCIS-related exceptions
- A stronger foundation for DSCSA readiness
Traceability that works in production requires more than feature support. It requires validated interoperability.
As supply chains become more interconnected, independent standards certification will increasingly separate theoretical compliance from operational reliability.
